KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ardelyx (ARDX) EBT (2016 - 2025)

Ardelyx (ARDX) has disclosed EBT for 12 consecutive years, with -$400000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT fell 108.55% year-over-year to -$400000.0, compared with a TTM value of -$60.6 million through Dec 2025, down 55.98%, and an annual FY2025 reading of -$60.6 million, down 55.98% over the prior year.
  • EBT was -$400000.0 for Q4 2025 at Ardelyx, up from -$867000.0 in the prior quarter.
  • Across five years, EBT topped out at $10.7 million in Q4 2022 and bottomed at -$45.2 million in Q2 2021.
  • Average EBT over 5 years is -$19.5 million, with a median of -$24.6 million recorded in 2022.
  • Peak annual rise in EBT hit 129.83% in 2023, while the deepest fall reached 366.19% in 2023.
  • Year by year, EBT stood at -$36.2 million in 2021, then soared by 129.52% to $10.7 million in 2022, then tumbled by 366.19% to -$28.5 million in 2023, then soared by 116.44% to $4.7 million in 2024, then crashed by 108.55% to -$400000.0 in 2025.
  • Business Quant data shows EBT for ARDX at -$400000.0 in Q4 2025, -$867000.0 in Q3 2025, and -$19.1 million in Q2 2025.